Facebook
Twitter
LinkedIn
Forward
Can an Aspirin a Day Keep Dementia at Bay?
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Target Audience
This article is intended for neurologists, family medicine/primary care practitioners, internists, neurologists, nurses, pharmacists, public health and prevention officials, and other members of the healthcare team who treat and manage elderly patients who may be at risk for cognitive decline.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Evaluate the effect of low-dose aspirin vs placebo on incident all-cause dementia, Alzheimer disease, mild cognitive impairment, and cognitive decline in older individuals in the United States and Australia, based on an analysis from the Aspirin in Reducing Events in the Elderly double-blind, placebo-controlled trial
- Assess the clinical implications of the effect of low-dose aspirin vs placebo on incident all-cause dementia, Alzheimer disease, mild cognitive impairment, and cognitive decline in older individuals in the United States and Australia, based on an analysis from the Aspirin in Reducing Events in the Elderly trial
- Outline implications for the healthcare team
Additional Information
News Author
Damian McNamara
Journalist, Medscape Psychiatry | Medscape Neurology
Disclosure: Damian McNamara has disclosed no relevant financial relationships.
CME Author
Laurie Barclay, MD
Freelance writer and reviewer, Medscape, LLC
Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.
Editor/CME Reviewer
Hazel Dennison, DNP, RN, FNP
Associate Director, Accreditation and Compliance, Medscape, LLC
Disclosure: Hazel Dennison, DNP, RN, FNP, CPHQ, CNE, has disclosed no relevant financial relationships.
CE Reviewer
Esther Nyarko, PharmD
Associate Director, Accreditation and Compliance, Medscape, LLC
Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Disclosures
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
For Physicians
Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For Nurses
Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.
For Pharmacists
Medscape, LLC designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number JA0007105-0000-20-077-H01-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
Available Credit
- 0.25 MOC
- 0.25 AMA PRA Category 1 Credit™
- 0.25 ANCC
This course is offered through Medscape. To take this course you will be redirected to Medscape's website. You must have an account with Medscape in order to complete this activity.
Mocingbird continues to work with our CME partner network to provide courses directly to you. We appreciate your patience as we work toward that goal!